NEWS
Our Latest News
ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products
Global private equity healthcare specialist ARCHIMED further expands its presence in the Consumer Health sector with the acquisition of Groupe Laboratoire Rivadis.
ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders
October
20,
2021
ARCHIMED’s NAMSA returns more than a third of investment
October
7,
2021
ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products
October
5,
2021
368